Effects of Maltodextrin-Fructose Supplementation on Inflammatory Biomarkers and Lipidomic Profile Following Endurance Running: A Randomized Placebo-Controlled Cross-Over Trial.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Sep 2024
Historique:
received: 07 08 2024
revised: 05 09 2024
accepted: 11 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Managing metabolism for optimal training, performance, and recovery in medium-to-high-level endurance runners involves enhancing energy systems through strategic nutrient intake. Optimal carbohydrate intake before, during, and after endurance running can enhance glycogen stores and maintain optimal blood glucose levels, influencing various physiological responses and adaptations, including transitory post-endurance inflammation. This randomized trial investigates the impact of a high-dose 2:1 maltodextrin-fructose supplementation to medium-to-high-level endurance runners immediately before, during, and after a 15 km run at 90% VO We evaluated inflammatory biomarkers and lipidomic profiles before the endurance tests and up to 24 h after. We focused on the effects of high-dose 2:1 maltodextrin-fructose supplementation on white blood cell count, neutrophil number, IL-6, cortisol, and CRP levels, as well as polyunsaturated fatty acids, ω-3 index, and AA/EPA ratio. This supplementation significantly reduced inflammatory markers and metabolic stress. Additionally, it may enhance the post-activity increase in blood ω-3 fatty acid levels and reduce the increase in ω-6 levels, resulting in a lower trend of AA/EPA ratio at 24 h in the treated arm. Adequate carbohydrate supplementation may acutely mitigate inflammation during a one-hour endurance activity of moderate-to-high intensity. These effects could be beneficial for athletes engaging in frequent, high-intensity activities.

Sections du résumé

BACKGROUND BACKGROUND
Managing metabolism for optimal training, performance, and recovery in medium-to-high-level endurance runners involves enhancing energy systems through strategic nutrient intake. Optimal carbohydrate intake before, during, and after endurance running can enhance glycogen stores and maintain optimal blood glucose levels, influencing various physiological responses and adaptations, including transitory post-endurance inflammation. This randomized trial investigates the impact of a high-dose 2:1 maltodextrin-fructose supplementation to medium-to-high-level endurance runners immediately before, during, and after a 15 km run at 90% VO
METHODS METHODS
We evaluated inflammatory biomarkers and lipidomic profiles before the endurance tests and up to 24 h after. We focused on the effects of high-dose 2:1 maltodextrin-fructose supplementation on white blood cell count, neutrophil number, IL-6, cortisol, and CRP levels, as well as polyunsaturated fatty acids, ω-3 index, and AA/EPA ratio.
RESULTS RESULTS
This supplementation significantly reduced inflammatory markers and metabolic stress. Additionally, it may enhance the post-activity increase in blood ω-3 fatty acid levels and reduce the increase in ω-6 levels, resulting in a lower trend of AA/EPA ratio at 24 h in the treated arm.
CONCLUSIONS CONCLUSIONS
Adequate carbohydrate supplementation may acutely mitigate inflammation during a one-hour endurance activity of moderate-to-high intensity. These effects could be beneficial for athletes engaging in frequent, high-intensity activities.

Identifiants

pubmed: 39339678
pii: nu16183078
doi: 10.3390/nu16183078
pii:
doi:

Substances chimiques

maltodextrin 7CVR7L4A2D
Biomarkers 0
Polysaccharides 0
Fructose 30237-26-4
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Stefano Righetti (S)

Department of Cardiology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.

Alessandro Medoro (A)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.

Francesca Graziano (F)

Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Bicocca Bioinformatics Biostatistics and Bioimaging Center B4, School of Medicine and Surgery, University of Milan-Bicocca, 20126 Milan, Italy.

Luca Mondazzi (L)

Sport Service Mapei, Sport Nutrition, 21057 Olgiate Olona, Italy.
School of Clinical Nutrition, University of Milan, 20126 Milan, Italy.

Serena Martegani (S)

Department of Biotechnology and Life Science, University of Insubria, 21100 Varese, Italy.

Francesco Chiappero (F)

Equipe Enervit Srl, Scientific Research Unit of Enervit Spa, 20126 Milan, Italy.

Elena Casiraghi (E)

Equipe Enervit Srl, Scientific Research Unit of Enervit Spa, 20126 Milan, Italy.
Department of Public Health, Experimental and Forensic Sciences, University of Pavia, 27100 Pavia, Italy.

Paolo Petroni (P)

Equipe Enervit Srl, Scientific Research Unit of Enervit Spa, 20126 Milan, Italy.

Graziamaria Corbi (G)

Department of Translational Medical Sciences, University of Naples "Federico II", 80138 Naples, Italy.

Riccardo Pina (R)

Equipe Enervit Srl, Scientific Research Unit of Enervit Spa, 20126 Milan, Italy.

Giovanni Scapagnini (G)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.

Sergio Davinelli (S)

Department of Medicine and Health Sciences "V. Tiberio", University of Molise, 86100 Campobasso, Italy.

Camillo Ricordi (C)

Cell Transplant Center, Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH